Sponsor

Juan A. Arnaiz

Clinical research sponsor

Published trials13
Recruiting shown0
Roles1
SourceClinicalTrials.gov

Clinical trials

13 shown
Hemodynamic Profile of Terlipressin and Octreotide in Patients With Cirrhosis and Portal Hypertension. A Randomised, Single Blinded Clinical Trial.NCT04353193 · lead sponsor · 2020-06-01
UNKNOWN
Safety & Efficacy of Dual Therapy With Raltegravir/LamivudineNCT02284035 · lead sponsor · 2015-09-27
COMPLETED
Cost-effectiveness of Different Antiretroviral Treatment in Patients HIV NaiveNCT02470650 · lead sponsor · 2015-06-01
WITHDRAWN
Immune Recovery in Advanced , ARV-naïve, HIV-1-infected Individuals Taking Dolutegravir or Ritonavir-boosted DarunavirNCT02337322 · lead sponsor · 2015-03-31
UNKNOWN
Treatment With Rosuvastatin Versus Switching PI (Protease Inhibitor) in Patients HIV With High Cholesterol LevelsNCT01935674 · lead sponsor · 2013-09-01
COMPLETED
Study to Evaluate the Activity and Tolerability of Lopinavir/Ritonavir and Lamivudine Bitherapy in HIV Patients With Viral SuppressionNCT01471821 · lead sponsor · 2011-10-01
COMPLETED
Efficacy of Statin Association With Standard Treatment in Prevention of Recurrent Hemorrhage in Patient With Cirrhosis and Variceal BleedingNCT01095185 · lead sponsor · 2010-11-01
COMPLETED
Clinical Trial to Assess the Effect of the Change of Efavirenz (EFV) for Lopinavir/Ritonavir (LPV/r) in Lipoatrophy in HIV-infected PatientsNCT00978237 · lead sponsor · 2009-10-01
COMPLETED
Effects of 2 Initial Standard Antiretroviral Combinations Therapies on Lipid MetabolismNCT00759070 · lead sponsor · 2008-09-01
UNKNOWN
A Phase I Study of Modified Vaccinia Virus Ankara (MVA-B) in Healthy Volunteers at Low Risk of HIV InfectionNCT00679497 · lead sponsor · 2008-06-01
COMPLETED
Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/MclNCT00532168 · lead sponsor · 2007-09-01
COMPLETED
Immune-based Therapy Pilot Study for the Treatment of Primary HIV Infection (PHI-IMD).NCT00979706 · lead sponsor · 2005-03-01
COMPLETED
Intermittent ART in Primary HIV InfectionNCT02300623 · lead sponsor · 2000-03-01
COMPLETED

Sponsor roles

lead sponsor13

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.